COVID-19 raises the risk of adverse birth outcomes, especially in women with HIV
Zero vertical transmissions from over 5000 pregnant women with undetectable HIV in France
Large disparities in dolutegravir uptake persist between men and women in low and middle-income countries
Will increasing viral load testing reduce HIV transmission through breast milk in low- and middle-income countries?
Greater weight gain in pregnancy linked to TAF-and-integrase inhibitor combinations
Half of Swiss mothers with HIV decide to breastfeed their baby when given the choice
Most countries with the greatest burden of HIV still don’t recommend dolutegravir for all
Who benefits when men attend antenatal care with their partners?
Taking isoniazid preventive therapy (IPT) during pregnancy not associated with adverse birth outcomes
